⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3610 | 0.77 | — | — | |
| Phenylacetylene SCHEMBL5174228 | 0.75 | TSHR (0.42) | — | |
| SCHEMBL20399742 | 0.75 | — | — | |
| SCHEMBL1756357 | 0.75 | — | — | |
| SCHEMBL2188836 | 0.73 | APP (0.57) | — | |
| SCHEMBL6296436 | 0.72 | ALDH1A1 (0.38) | — | |
| SCHEMBL1978211 | 0.71 | — | — | |
| SCHEMBL10736631 | 0.71 | TSHR (0.50) | — | |
| SCHEMBL27622104 | 0.70 | TSHR (0.42) | — | |
| Magnesium Chloride Anhydrous SCHEMBL27811650 | 0.70 | TSHR (0.42) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 920 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118265702-A | Microbiocidal isonicotinamide derivatives | 先正达农作物保护股份公司 | 2024-06-28 | — | — | CN | claimed |
| WO-2024102177-A1 | COMBINATION THERAPIES FOR THE TREATMENT OF BRAIN CANCER | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-05-16 | — | — | WO | claimed |
| US-20240140983-A1 | SINGLE STRANDED DNA ENZYME INHIBITORS | MASSEY UNIVERSITY (NZ) | 2024-05-02 | — | — | US | claimed |
| CN-117940504-A | Triazole containing polymers and methods of use thereof | 威廉马什莱斯大学 | 2024-04-26 | — | — | CN | claimed |
| WO-2024081447-A1 | EGFR INHIBITORS FOR TREATING LUNG CANCER | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-04-18 | — | — | WO | claimed |
| CN-117362200-B | Benzenemethylamine compound and synthesis method and application thereof | 肇庆学院 | 2024-04-09 | — | — | CN | claimed |
| CN-112543781-B | Polybenzimidazole oligomers having reactive end groups | PBI性能产品公司 | 2024-02-20 | — | — | CN | claimed |
| CN-114181222-B | Synthesis method and application of azaheterocyclic compound with anti-tumor effect | 桂林理工大学 | 2024-02-06 | — | — | CN | claimed |
| CN-117362200-A | Benzenemethylamine compound and synthesis method and application thereof | 肇庆学院 | 2024-01-09 | — | — | CN | claimed |
| WO-2023244639-A1 | METHODS OF PREDICTING CNS CANCER RESPONSE TO TREATMENT WITH EGFR INHIBITORS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-12-21 | — | — | WO | claimed |
| US-6376492-B1 | GUANIDINE DERIVATIVES | MEDIVIR AB (SE) | 2002-04-23 | — | — | US | claimed |
| WO-1999001442-A1 | TRIAZINE DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS | ZENECA LIMITED (GB) | 1999-01-14 | — | — | WO | claimed |
| EP-0888351-A1 | PYRIMIDO 5,4-D]PYRIMIDINES, MEDICAMENTS CONTAINING THESE COMPOUNDS, THEIR USE AND PROCESS FOR THEIR PRODUCTION | Dr. Karl Thomae GmbH (DE) | 1999-01-07 | — | — | EP | claimed |
| US-5849769-A | N-arylalkyl-N-heteroarylurea and guandine compounds and methods of treating HIV infection | MEDIVIR AB (SE) | 1998-12-15 | — | — | US | claimed |
| EP-0706514-B1 | COMPOUNDS AND METHODS FOR INHIBITION OF HIV AND RELATED VIRUSES | MEDIVIR AB (SE) | 1998-11-18 | — | — | EP | claimed |
| US-5821240-A | ENZYME INHIBITORS, SIGNAL INHIBITORS FOR ANTIINFLAMMATORY AGENTS, ANTICARCINOGENIC AGENTS, ANTITUMOR AGENTS AND HORMONE INHIBITORS | DR. KARL THOMAE GMBH (DE) | 1998-10-13 | — | — | US | claimed |
| WO-1997032880-A1 | PYRIMIDO[5,4-D]PYRIMIDINES, MEDICAMENTS CONTAINING THESE COMPOUNDS, THEIR USE AND PROCESS FOR THEIR PRODUCTION | DR. KARL THOMAE GMBH (DE) | 1997-09-12 | — | — | WO | claimed |
| JP-H09502702-A | — | — | 1997-03-18 | — | — | JP | claimed |
| EP-0706514-A1 | COMPOUNDS AND METHODS FOR INHIBITION OF HIV AND RELATED VIRUSES | MEDIVIR AB (SE) | 1996-04-17 | — | — | EP | claimed |
| WO-1995006034-A1 | COMPOUNDS AND METHODS FOR INHIBITION OF HIV AND RELATED VIRUSES | MEDIVIR AB (SE) | 1995-03-02 | — | — | WO | claimed |